Adrenaline for Treatment of Anaphylaxis

pdfASCIA PCC Adrenaline for Treatment of Anaphylaxis 2023133.86 KB

This document has been developed by ASCIA, the peak professional body of clinical immunology/allergy specialists in Australia and New Zealand. ASCIA information is based on published literature and expert review, is not influenced by commercial organisations and is not intended to replace medical advice. For patient or carer support contact Allergy & Anaphylaxis Australia or Allergy New Zealand.

Anaphylaxis is the most severe type of allergic reaction and should always be treated as a medical emergency. Anaphylaxis requires immediate treatment with adrenaline (epinephrine), which is injected into the outer mid-thigh muscle. Delayed treatment can result in fatal anaphylaxis. 

Adrenaline is a natural hormone released in response to stress. When injected, adrenaline rapidly reverses the effects of anaphylaxis by reducing throat swelling, opening the airways, and maintaining heart function and blood pressure.

Management of anaphylaxis

To manage anaphylaxis it is important to:

  • Identify and avoid the cause where possible.
  • Have an ASCIA Action Plan for Anaphylaxis and adrenaline injector close by (easily accessible) to treat if accidental exposure occurs.

ASCIA Action Plans for Anaphylaxis (emergency response plan) must be completed by a doctor or nurse practitioner and should be kept with the adrenaline injector as the plans include instructions on when and how to give an adrenaline injector.

Adrenaline injectors contain a single, fixed dose of adrenaline, and have been designed to be given by non-medical people, such as a friend, teacher, children's education/care worker, parent, passer-by or by the patient themselves (if they are not too unwell to do this).

Use of adrenaline in anaphylaxis assists the body's natural response

The body's natural response to anaphylaxis is to release adrenaline, a natural antidote to some of the chemicals released as part of a severe allergic reaction (anaphylaxis). Therefore, injected adrenaline assists the body's natural response.

As adrenaline is destroyed by enzymes in the stomach, it needs to be injected. It cannot be given by mouth, and inhaled adrenaline is ineffective.

Adrenaline injected into the outer mid-thigh muscle works rapidly to reduce throat swelling, open up the airways and maintain heart function and blood pressure. It is the only medication available for the immediate treatment of anaphylaxis.

The potential risks of NOT giving adrenaline far outweigh the potential risks of giving adrenaline

If anaphylaxis is suspected, give the adrenaline injector as not giving adrenaline can be more harmful than giving it, even when it may not have been necessary. If in doubt, give the adrenaline injector.

Common side effects of adrenaline include increased heart rate, trembling and paleness. Therefore, someone may look unwell even after the adrenaline injector has been given.

Whilst needles may sometimes hurt, you have to remember why you are using it and that adrenaline can be life-saving.

Adrenaline should be injected into the muscle of the outer mid thigh

Adrenaline is absorbed most rapidly when injected into the outer mid-thigh muscle. Injecting into the outer mid-thigh also makes it extremely unlikely that damage to any nerves or tendons will occur, or that it will be inadvertently injected into an artery or vein. It is also the least painful part of the body to give an injection.

It is important to lay the person flat – do not allow them to stand or walk. If breathing is difficult allow them to sit. If unconscious, place them in the recovery position (on their side). They must not walk to or from the ambulance even if they appear to have improved or recovered.

Adrenaline injectors available in Australia and New Zealand  

EpiPen® and Anapen® adrenaline injector devices are available on PBS authority prescription in Australia. EpiPen® is also available in New Zealand (Pharmac listed since 1 February 2023).

There are three doses of adrenaline injectors:

  • Adrenaline injectors (150 micrograms) are usually prescribed for children weighing 7.5-20kg (e.g. EpiPen® Jr or Anapen® 150).
  • Adrenaline injectors (300 micrograms) are usually prescribed for children over 20kg and adults, including pregnant women (e.g. EpiPen® or Anapen® 300).
  • Adrenaline injectors (300 or 500 micrograms) are usually prescribed for children or adults over 50kg, including pregnant women (e.g. EpiPen® or Anapen® 300 or Anapen® 500).

Each adrenaline injector contains a single fixed dose of adrenaline. It is designed to be used as a first aid device by people without any medical or nursing training. Instructions for adrenaline injectors are shown on the ASCIA Action Plans for Anaphylaxis that are available on the ASCIA website 

It is important to check that you have been given the ASCIA Action Plan which matches the device you have been prescribed.

If you or your child has been prescribed an adrenaline injector, it is important that you learn and practise how to use it, using a trainer device, that does not contain adrenaline. It is recommended that you practise using the trainer device at least every three to four months.

Store adrenaline at room temperature

Adrenaline injectors should be stored in a cool dark place at room temperature, but NOT refrigerated as this can damage the injector mechanism. Whilst they should be kept out of the reach of small children, adrenaline injectors must be readily available when needed and not in a locked cupboard. The shelf life of adrenaline is normally one or two years from the date of supply. You need to regularly check the expiry date on the adrenaline injector.

© ASCIA 2023

ASCIA is the peak professional body of clinical immunology/allergy specialists in Australia and New Zealand. For more information go to

To support allergy/immunology research go to

Content updated March 2023

Mod ASCIA Member
Donate to AIFA
go to NAC website

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia